# Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia

> **NCT02992938** · PHASE4 · COMPLETED · sponsor: **University of Chile** · enrollment: 50 (actual)

## Conditions studied

- Hyperalgesia
- Opioid-Related Disorders

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT02992938
- **Lead sponsor:** University of Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2018-09-28
- **Final completion:** 2018-09-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992938, "Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02992938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*